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T reg cells play an important role in regulating 
immunity and have an essential function in pre­
venting fatal autoimmune disease (Sakaguchi 
et al., 2006; Ziegler, 2006). T reg cells come in 
at least two flavors, referred to as intrathymically 
and extrathymically induced T reg cells (Chen   
et al., 2003; Apostolou and von Boehmer, 
2004; Kretschmer et al., 2005; Mucida et al., 
2005;  Hsieh  et  al.,  2006;  Pacholczyk  et  al., 
2006; Sun et al., 2007). Recently, it was shown 
that retinoic acid (RA), produced by special­
ized  DCs  in  the  gut  (Benson  et  al.,  2007; 
Coombes et al., 2007; Mucida et al., 2007; Sun 
et al., 2007), can enhance the peripheral con­
version of naive CD4+ T cells into T reg cells, 
a process that is dependent on TGF­–induced 
signaling both in vitro and in vivo (Chen et al., 
2003; Curotto de Lafaille et al., 2004; Fantini 
et al., 2004; Kretschmer et al., 2005).
Initially, it was hypothesized that RA has a 
direct effect on the converting cells either by 
counteracting the negative effect of IL­6 sig­
naling (Mucida et al., 2007) or by preventing 
the formation of AP­1 (von Boehmer, 2007). 
In contrast to these models, a more recent analy­
sis of carefully separated T cell subsets concluded 
that RA elicits its effect through “contaminat­
ing” activated CD44hi cells that secrete cytokines 
in response to antigenic stimulation, and these 
cytokines in turn prevent the conversion of na­
ive T cells into T reg cells. It was concluded that 
RA prevented cytokine production by CD44hi 
cells, thereby enhancing T reg cell conversion 
(Hill et al., 2008). Independent studies, how­
ever, argued for a more direct role of RA on the 
conversion of T cells (Takaki et al., 2008; Xiao 
et al., 2008). In a recent exchange of letters (Hill 
et al., 2009; Mucida et al., 2009), it was pro­
posed that RA directly affects conversion of 
naive T cells (Mucida et al., 2009) and that this 
effect could be caused by inhibition of cytokine 
secretion by naive T cells (Hill et al., 2009). It 
remains unclear, however, whether the effect of 
RA on T reg cell conversion is always caused by 
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It has been reported that retinoic acid (RA) enhances regulatory T (T reg) cell conversion 
by inhibiting the secretion of cytokines that interfere with conversion. This report shows 
that these conclusions provide a partial explanation at best. First, RA not only interfered 
with cytokine secretion but also with the ability of these cytokines to inhibit T reg cell 
conversion of naive T cells. Furthermore, RA enhanced conversion even in the absence of 
inhibitory cytokines. The latter effect depended on the RA receptor  (RAR) but did 
not require Smad3, despite the fact that RA enhanced Smad3 expression. The RAR1 
isoform was not essential for RA-dependent enhancement of transforming growth factor 
–driven conversion, suggesting that conversion can also be mediated by RAR2. Inter-
leukin (IL)-6 strongly reduced RAR expression levels such that a deficiency of the 
predominant RAR1 isoform leaves too little RAR2 for RA to inhibit the generation of 
Th17 cells in the presence of IL-6.
© 2009 Nolting et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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not Smad2 transcription in naive T cells. Of note, deficiency 
of the RAR1 isoform interferes with the TGF­– plus IL­6–
dependent conversion of Th17 cells but has much less of an 
effect on T reg cell conversion. This is because of the fact that 
IL­6 severely reduces RAR expression levels.
RESULTS AND DISCUSSION
Direct impact of RA on T reg cell conversion depends  
on mode of T cell activation
When CD4+ T cells were depleted of CD44hi cells (Fig. 1 A) 
and subjected to an in vitro TGF­–dependent T reg cell 
conversion assay, the effect of RA on the conversion process   
was clearly diminished, but not abolished, when cells were cul­
tured with CD3 and CD28 antibodies at a 1:1 ratio (Fig. 1 B). 
In fact, the magnitude of the RA­enhancing effect depended 
on co­stimulation because it was reduced when only CD3 
the inhibition of cytokine secretion or whether there are ad­
ditional mechanisms that are cytokine independent and might 
involve direct regulation of genes, such as FoxP3, that are 
expressed in T reg cells.
We have investigated the role of RA in the T reg cell 
conversion process in more detail by analyzing the contribu­
tion of CD44hi cells, titrating co­stimulating CD28 antibod­
ies as well as cytokines, and by addressing molecular pathways 
involved in the conversion process. The results show that 
RA can interfere with the negative effect of co­stimulation 
and certain cytokines on naive T cells rather than directly in­
hibiting cytokine secretion. We also found that RA enhances 
T reg cell conversion of naive T cells in the absence of inhib­
itory cytokines. The latter mechanism depended on the ex­
pression of RA receptor  (RAR) but was largely Smad 
independent, in spite of RA’s ability to increase Smad3 but 
Figure 1.  Direct effect of RA on T reg cell conversion by counteracting co-stimulation. (A) CD44hi cells inhibit TGF-–mediated Foxp3 expres-
sion. Comparison of T reg cell conversion of CD4+ naive T cells from Foxp3-GFP reporter mice activated with anti-CD3 and anti-CD28 and 2.5 ng/ml TGF-  
in the presence or absence of CD44hi cells. Numbers indicate percentages of Foxp3-expressing cells gated on CD4+ cells. Shown is one experiment repre-
sentative of six independent experiments. (B) RA enhances Foxp3 expression in purified naive CD4+ T cells over a range of TGF- concentrations. Continu-
ous lines show the frequency of Foxp3+ cells of cultures in the presence of CD44hi cells (blue) or in the absence of CD44hi cells (red). Dashed lines indicate 
cultures that contained 2.5 nM RA. Data are from three independent experiments. (C) RA directly counteracts co-stimulation. Naive T cells from Foxp3 
reporter mice were cultured with CD3 antibodies alone (red) or CD3 and CD28 antibodies (blue) at a ratio of 1:2 in the presence of the indicated TGF- 
concentrations. Dashed lines represent cultures containing 2.5 nM RA. Representative data are shown of three independent experiments.JEM VOL. 206, September 28, 2009  2133
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Figure 2.  RA enhances T reg cell conversion independently of secreted cytokines and neutralizes the effect of cytokines on naive T cells.  
(A, left) Cytokines in supernatants of stimulated naive or CD44hi cells. Naive CD4+ T cells or CD44hi cells were activated with anti-CD3 and anti-CD28, and 
the supernatants were measured after 48 h by ELISA for IL-4, IFN-, and IL-21. In some cultures 0.6 ng/ml TGF- was added. (right) Supernatants of CD44hi 
but not naive T cells contain cytokines inhibiting T reg cell conversion. Conversion of naive T cells is enhanced by a direct effect of RA: naive CD4+ T cells 
were activated with anti-CD3 and anti-CD28 and 0.6 ng/ml TGF- in medium or supernatant from CD44hi or naive CD4+ T cells, and diluted with fresh 
media at a ratio of 1:1 in the presence (open histogram) or absence (shaded histogram) of 2.5 nM RA. Representative data (means ± SEM) are shown for 
two independent experiments. (B) RA neutralizes the adverse effect on conversion of various cytokines. 0.1 ng/ml of recombinant IL-4, IFN-, and IL-21 
were added individually or in combination to cultures of naive CD4+ T cells activated with anti-CD3 and anti-CD28 and 0.3 ng/ml TGF- in the presence 
(open histogram) or absence (shaded histogram) of 2.5 nM RA. Shown are representative FACS data from three individual experiments. (C) Antibodies to 
IL-4, IFN-, and IL-21 can neutralize the inhibitory effect of CD44hi cell supernatant on T reg cell conversion. (D) RA enhances conversion of IL-4–deficient 
naive T cells. Naive CD4+ T cells were activated with anti-CD3 and anti-CD28 and TGF- in the presence (open histogram) or absence (shaded histogram) 
of RA. One representative experiment out of three is shown.2134 RA-ENHANCED T REG CELL CONVERSION INDEPENDENT OF INHIBITORY CYTOKINES | Nolting et al.
Figure 3.  RA-enhanced expression and phosphorylation of Smad3. (A) Naive CD4+ T cells were activated with anti-CD3 alone or anti-CD3 and anti-
CD28 for 12 h. (top) Total RNA was isolated, and expression of Smad3 mRNA was determined by quantitative real-time PCR. Data (means ± SEM) are 
representative of three independent experiments. (middle) Cell lysates were separated by SDS-PAGE gel, and total Smad3, p-Smad3, and p-Smad2 were 
analyzed by immunoblotting with specific antibodies. For quantification, the ratio of total Smad3/-actin as well as the ratios of p-Smad3/-actin and  
p-Smad2/-actin were determined by densitometric analysis. Nuclear and cytoplasmatic extracts were analyzed by immunoblotting with specific antibodies. 
Cells were fixed and stained for confocal analysis by a Smad3 antibody. Data are representative of three to five independent experiments. (bottom) T reg 
cell conversion of naive CD4+ T cells from Smad3/ or Smad4/ or WT control mice activated with anti-CD3/CD28 in the presence of 0.3 ng/ml TGF- JEM VOL. 206, September 28, 2009  2135
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In conclusion, there is a direct effect of RA on Foxp3 ex­
pression that does not involve reversing the inhibitory effect 
of secreted cytokines. IL­4 in particular has been shown to 
lead to a marked decrease of Foxp3 expression, and this cyto­
kine could conceivably be secreted at low levels by naive 
T cells (Hill et al., 2008; Takaki et al., 2008). However, we 
show that RA also enhances the conversion of IL­4–deficient 
naive T cells into FoxP3+ T reg cells (Fig. 2 D).
RA increases Smad3 but nevertheless enhances T reg cell 
conversion independently of Smad3
The data in Figs. 1 and 2 indicate that RA can directly affect 
the conversion of naive T cells into Foxp3+ T reg cells in the 
absence of secreted cytokines. However, these experiments 
did not address the molecular mechanism by which this was 
achieved. Because RA cooperates with TGF­ in T reg cell con­
version, we analyzed the impact of RA on TGF­–dependent 
signaling pathways, especially Smad proteins, because the 
Smad3 gene contains a putative single RA response element 
(Schug et al., 2007).
Indeed, RA increased Smad3 RNA and protein levels 
in naive T cells and, in concert with TGF­, yielded more 
phosphorylated Smad3 in the nucleus (Fig. 3 A). Although 
these data could provide a mechanism to explain how RA 
cooperates with TGF­ in T reg cell conversion, experi­
ments with Smad­deficient mice indicated that this pathway 
does not play an essential role in RA­dependent T reg cell 
conversion (Fig. 3 B). In contrast, TGF­–dependent T reg 
cell conversion is much more Smad dependent: in the pres­
ence of TGF­, Smad3­deficient cells converted less effi­
ciently than did WT cells, with the percentage of Foxp3+ 
cells dropping from 48 to 17%. In spite of this decrease, RA 
could still strongly enhance the conversion of Smad3­defi­
cient naive T cells into Foxp3­expressing T reg cells.
Smad4 is essential for shuttling phosphorylated Smad3 or 
Smad2 into the nucleus, and for stabilizing Smad2/3 DNA 
complexes (Massagué et al., 2005). Consistent with this role 
of Smad4, TGF­–dependent conversion was strongly re­
duced in Smad4­deficient versus WT naive T cells (9 vs. 43%). 
Again, RA considerably enhanced the conversion of Smad4­
deficient naive T cells into FoxP3+ T reg cells (Fig. 3 B). 
These  results  indicate  that  TGF­–dependent  in  vitro 
conversion  depends  largely  on  Smad  proteins,  whereas 
RA­dependent enhancement of this conversion does not. 
Of note, even in Smad4­deficient mice, some Smad3 does 
enter the nucleus in the presence of TGF­, which could 
explain why the Smad4 deficiency does not entirely abolish 
T reg cell conversion in vitro and has little effect on the 
proportion of T reg cells in various lymphoid organs in vivo 
antibodies were used. Adding CD28 antibodies in excess (2:1) 
decreased the conversion rate in the absence of RA, and RA 
could fully reverse this decrease (Fig. 1 C). Thus, depending 
on the conditions under which naive T cells are stimulated, 
RA can have a direct effect on the conversion of naive   
T cells (Mucida et al., 2009), and this becomes more apparent 
under conditions of strong co­stimulation (Fig. 1; Benson 
et al., 2007).
RA directly neutralizes the adverse effect of cytokines  
on T reg cell conversion
These observations could be interpreted to suggest that strong 
co­stimulation results in cytokine release from the stimulated 
naive T cells that then interferes with conversion, as suggested 
previously (Hill et al., 2009). According to this assumption, 
RA could interfere with the production of cytokines by both 
CD44lo and CD44hi cells. Alternatively, but not mutually 
exclusive, one could argue that RA interferes with the effect 
of cytokines on naive T cells, as postulated by others (Takaki 
et al., 2008; Xiao et al., 2008). Finally, RA could directly 
enhance T reg cell conversion independently of cytokine se­
cretion. In fact, it appears that all of these scenarios apply.
To address these issues, CD44hi and naive T cells were 
stimulated and their supernatants were tested for the capacity 
to inhibit TGF­–dependent conversion in the presence or 
absence of RA. As shown in Fig. 2, inhibitory cytokines 
were produced by CD44hi but not by naive T cells, and these 
cytokines could inhibit conversion irrespective of whether 
the CD44hi cells were stimulated in the presence or absence 
of TGF­. IL­4 and IFN­ could be detected in the super­
natants of CD44hi cells, and antibodies to IL­4, IFN­, and 
IL­21 could neutralize the inhibitory effect of the superna­
tant on T reg cell conversion (Fig. 2 C). Furthermore, RA 
could reverse the inhibitory effect of IL­4, IFN­, and IL­21 
on the TGF­–dependent conversion of naive T cells in a 
dose­dependent manner (Fig. S2).
These experiments therefore indicate that RA can affect 
T reg cell conversion in multiple ways. One mechanism in­
volves interfering with the secretion of cytokines by CD44hi 
cells (Hill et al., 2008), and another involves interfering with 
the inhibitory effect of cytokines on the TGF­–dependent 
conversion of naive T cells. A third mechanism involves en­
hancement of T reg cell conversion in the absence of any 
inhibitory effect of secreted cytokines. Indeed, we showed 
that, contrary to prior assumptions (Hill et al., 2009), naive 
T cells do not produce any inhibitory cytokines when cultured 
with anti­CD3/28 in the presence of TGF­. Conceivably, 
in the latter two scenarios RA could operate by the same mech­
anism, for instance by directly enhancing Foxp3 expression.
or TGF- plus 2.5 nM RA. (B, top) Representative FACS plots are shown (n = 3 independent experiments). (middle) Cell lysates of naive CD4+ cells from 
Smad3/ and WT control mice were cultured for 12 h (as in A, bottom) and separated by SDS-PAGE gel, and total Smad3 and Smad2 were detected by 
immunoblotting. Representative data out of four independent experiments are shown. (bottom) Naive CD4+ T cells from Smad4/ or WT control mice 
were fixed and stained by Smad3 antibodies and analyzed by confocal microscopy. The arrows indicate translocation of Smad3 into the nucleus. Repre-
sentative data are shown (n = 3 independent experiments).
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(Yang et al., 2008), with the possible exception of the gut 
(Fig. S3). However, in vivo conversion could be largely 
Smad independent.
Role of RAR1 and RAR2 isoforms
The final analysis addressed the role of RAR in RA­ 
enhanced conversion of naive T cells in the absence of 
CD44hi­activated T cells. As shown in Fig. 4, RA­enhanced 
conversion was abolished in RAR­deficient naive T cells, 
whereas there was much less of an effect in the absence of 
RAR1 alone. This indicates that both RAR isoforms can 
mediate the RA­dependent enhancement of T reg cell con­
version. In contrast, the negative effect of RA on TGF­– 
and IL­6–dependent conversion of naive T cells into Th17 
cells was much more dependent on the RAR1 isoform. 
Both RAR and RAR1 deficiency completely blocked the 
negative impact of RA on Th17 conversion (Fig. 4 A). When 
analyzing total RAR expression in cells cultured in the ab­
sence or presence of IL­6, it became clear that IL­6 strongly 
reduced RAR expression (Fig. 4 B). Thus, a deficiency of 
the predominant RAR1 isoform leaves very little RAR2 
expressed in cells cultured in the presence of IL­6 (Fig. 4 B). 
It is therefore possible that RAR1 and perhaps also RAR2 
can mediate RA­dependent enhancement of T reg cell con­
version and the inhibitory effect of RA on the generation   
of Th17 cells. However, there is too little RAR2 left in 
RAR1­deficient cells in IL­6 containing cultures to reach 
definitive conclusions about RAR2.
Figure 4.  RAR deficiency but not RAR1 deficiency blocks T reg cell conversion. (A) Naive CD4+ T cells were activated with anti-CD3 and anti-CD28 
for 3 d under the indicated conditions, and T reg cell or Th17 conversion was analyzed by intracellular staining of Foxp3 or IL-17 (percentages are indicated). 
Representative FACS plots are shown of three independent experiments. (B) IL-6 reduces the RAR content of naive T cells. Naive CD4+ T cells were activated 
as in A. After 24 h, cells were collected for the determination of RAR by TaqMan quantitative PCR. Data are representative of three independent experiments.JEM VOL. 206, September 28, 2009  2137
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bon  Laboratory  (Chapellier  et  al.,  2002).  RAR1­deficient  mice  were 
provided by P. Li (Li et al., 1993), and Foxp3­GFP reporter mice were pro­
vided by A. Rudensky (Memorial Sloan­Kettering Cancer Center, New 
York, NY; Fontenot et al., 2005). Smad3­deficient mice were provided by 
C. Stuelten. Founder animals for the Smad3­BALB/c colony were a gift 
from L.W. Bach (Aarhus University Hospital, Aarhus, Denmark) and were 
bred at the facility at the National Cancer Institute, whereas Smad4Lck Cre 
mice were provided by B.­G. Kim. All mice were maintained in a pathogen­
free facility, and all procedures were in accordance with the approved pro­
tocols and guidelines of the Animal Care and Use Committee of the 
Dana­Farber Cancer Institute.
Cell  sorting  and  flow  cytometry. mAbs specific for CD4 (RM4­5), 
CD25 (PC61), CD44 (IM7), CD62L (MEL­14), Foxp3 (FJK­16s), and IL­17 
were purchased from BD or eBioscience and were used as biotin, FITC, PE, 
PerCP­Cy5.5, allophycocyanin (APC), or Pacific blue conjugates. For Fig. 1 
(A and B), CD4+CD44loCD62LhiCD25Foxp3­GFP T cells (without 
CD44hi cells) or CD4+CD62LhiCD25Foxp3­GFP T cells (with CD44hi 
cells), T cells (Sun et al., 2007) were sorted from spleens and lymph nodes of 
6–8­wk­old mice using a cell sorter (FACSAria; BD). For all other experi­
ments, highly purified naive CD4+ T cells were FACS sorted as CD4+CD44lo 
CD62LhiCD25Foxp3­GFP  T  cells  (Foxp3­GFP  reporter  mice)  or 
CD4+CD44loCD62LhiCD25 T cells (Fig. S1).
In vitro activation and conversion assays. For T reg cell conversion as­
says, T cells were activated with plate­bound anti­CD3 alone or together 
with anti­CD28 antibodies at a concentration of 5 µg/ml in the presence of 
100 U/ml of recombinant mouse IL­2 (PeproTech) for 3 d in a 96­well flat­
bottom plate. Naive T cells were cultured at a concentration of 0.5 × 105 
cells/well. Conversion assays for Western blot analysis were performed in 
24­well flat­bottom plates with 106 naive T cells per well. Some cultures 
were also treated with 2.5 nM of all­trans RA (Sigma­Aldrich); the doses of 
recombinant TGF­ and recombinant mouse IL­4, IL­21, or IFN­ indi­
cated in the figures (at the indicated concentrations; PeproTech and R&D 
Systems); or blocking antibodies specific for 5 µg/ml IL­4, IL­21, or IFN­ 
(R&D Systems). For Fig. 2 A, supernatants were harvested after 48 h from 
cultures activated with anti­CD3 and anti­CD28, and the concentration of 
IL­4, IL­21, and IFN­ was analyzed by a mouse ELISA set (OptEIA; BD). 
For further experiments, the supernatant was diluted with fresh media at a 
ratio of 1:1. For Th17 conversion assays, 5 × 105 sorted naive T cells were 
stimulated with plate­bound anti­CD3/CD28 antibodies in the presence of 
30 ng/ml IL­6 and IFN­ blocking antibody. In some cultures, 1 ng/ml of 
recombinant TGF­ and 2.5 nM RA were added. In all cases, cultures were 
examined by FACS for expression of GFP (Foxp3­GFP reporter), or intra­
cellular staining for Foxp3 or IL­17 was performed.
RNA isolation, real-time PCR, and immunoblotting. Total RNA was 
prepared from cells cultured for 12 h in the T reg cell conversion assay using 
the RNeasy kit (QIAGEN) followed by DNase digestion (QIAGEN). cDNA 
was synthesized from total RNA using Superscript II RT and oligo(dT) 
(Invitrogen) according to the manufacturer’s recommendations. Real­time 
RT­PCR was performed on a thermal cycler (ABI PRISM; Applied Bio­
systems) using SYBR green PCR core reagents (Applied Biosystems). Oli­
gonucleotide primer sequences for Smad3 and HPRT1 were as follows: 
Smad3­F, 5­CTGGGCCTACTGTCCAATGT­3; Smad3­R, 5­CGAT­
GTAGTAGAGCCGCACA­3; Hprt1­F, 5­AGTGTTGGATACAGGC­
CAGAC­3; and Hprt1­R, 5­CGTGATTCAAATCCCTGAAGT­3. 
TaqMan quantitative PCRs were performed with TaqMan gene expression 
assays (Applied Biosystems) for GAPDH (Mm99999915_g1) and RAR 
(Mm00436264_m1). For Western blot analysis, cells were lysed after 12 h in 
RIPA buffer or for nuclear and cytoplasmatic extracts by Ne­per (Thermo 
Fisher Scientific) according to the manufacturer’s instructions, supplemented 
with protease inhibitor cocktail (Sigma­Aldrich). 20­µg lysates were sepa­
rated on 4–20% SDS­PAGE and transferred onto nitrocellulose membrane 
(Millipore). Nonspecific binding was blocked by incubation in blocking 
The data presented in this report confirm that “contami­
nating” CD44hi­activated T cells can have an influence on the 
RA­dependent enhancement of TGF­–dependent T reg 
cell conversion. This is particularly true under conditions of 
limited co­stimulation, where most of the RA­dependent en­
hancement may be caused by interference with cytokine pro­
duction by CD44hi cells (Hill et al., 2008). However, even 
under these conditions, RA can also directly interfere with the 
inhibitory impact of exogenous cytokines on T reg cell con­
version of naive T cells. Furthermore, RA can interfere di­
rectly with the negative impact of co­stimulation on T reg cell 
conversion of naive T cells and can enhance T reg cell con­
version of naive T cells independently of secreted cytokines.
When analyzing the role of Smad proteins in TGF­– and 
RA­dependent conversion, we find that RA can increase Smad3 
expression and the accumulation of phosphorylated Smad3 in 
the nucleus, in accord with previous findings (Xiao et al., 2008). 
However, this pathway was not essential for RA­enhanced, 
TGF­–dependent conversion because the enhancing effect of 
RA was still discernible in Smad3­deficient naive T cells. On the 
other hand, in vitro conversion of naive T cells in response to 
TGF­ alone is dependent on Smad proteins. It is of interest that 
Smad4­deficient mice do not exhibit abnormalities in the pro­
portion of T reg cells in various lymphoid organs, with the pos­
sible exception of the gut (Fig. S3). This could indicate that 
other mechanisms, such as Smad4­independent nuclear localiza­
tion of Smad3, could compensate for the Smad4 deficiency in 
vivo or that the generation of the intestinal T reg cells is more 
Smad dependent than is the accumulation of T reg cells in other 
lymphoid organs. Irrespective of in vivo conversion mechanisms, 
TGF­–dependent in vitro conversion is largely dependent on 
Smad proteins, whereas RA­dependent enhancement of con­
version is not. The direct enhancement of T reg cell conversion 
of naive T cells by RA in the absence of inhibiting cytokines is 
entirely dependent on RAR and can be mediated by both re­
ceptor isoforms. IL­6 reduces the total RAR content of naive 
T cells such that in the absence of the predominantly expressed 
RAR1 isoform there is too little RAR2 left to address its 
role in inhibiting the generation of Th17 cells.
Presently, we have only limited insight into how RA 
could enhance T reg cell conversion and interfere with Th17 
conversion in an RAR­dependent manner. It has been sug­
gested that RAR can regulate Foxp3 expression by binding 
to regulatory sequences in the Foxp3 gene, thereby counter­
acting negative effects of cytokine­induced STAT proteins 
(Takaki et al., 2008) on Foxp3 expression. However, it is also 
possible that the effect of RAR is more indirect, for instance 
through interfering with the function of AP­1 (Nicholson   
et al., 1990; Salbert et al., 1993), which could negatively affect 
Foxp3–NFAT complexes required for Foxp3­dependent gene 
regulation (Wu et al., 2006; von Boehmer, 2007).
MATERIALS AND METHODS
Mice. C57BL/6J, C57BL/6­Il4/ mice were purchased from the Jackson 
Laboratory. RAR­deficient mice were provided by J. Hill (Harvard Medi­
cal School, Boston, MA). The mouse was originally generated in the Cham­2138 RA-ENHANCED T REG CELL CONVERSION INDEPENDENT OF INHIBITORY CYTOKINES | Nolting et al.
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